Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20145658rdf:typepubmed:Citationlld:pubmed
pubmed-article:20145658lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C0056695lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C0475224lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C1415299lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20145658lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:20145658pubmed:issue8lld:pubmed
pubmed-article:20145658pubmed:dateCreated2010-8-3lld:pubmed
pubmed-article:20145658pubmed:abstractTextPrevious exposure to a nonlethal ischemic insult protects the brain against subsequent harmful ischemia. N-methyl-D-aspartate (NMDA) receptors are a highly studied target of neuroprotection after ischemia. Recently, NMDA receptor subtypes were implicated in neuronal survival and death. We focused on the contribution of NR2A and cyclic-AMP response element (CRE)-binding protein (CREB) signaling to ischemic tolerance using primary cortical neurons. Ischemia in vitro was modeled by oxygen-glucose deprivation (OGD). Ischemic tolerance was induced by applying 45-mins OGD 24 h before 180-mins OGD. Sublethal OGD also induced cross-tolerance against lethal glutamate and hydrogen peroxide. After sublethal OGD, expression of phosphorylated CREB and CRE transcriptional activity were significantly increased. When CRE activity was inhibited by CREB-S133A, a mutant CREB, ischemic tolerance was abolished. Inhibiting NR2A using NVP-AAM077 attenuated preconditioning-induced neuroprotection and correlated with decreased CRE activity levels. Activating NR2A using bicuculline and 4-aminopiridine induced resistance to lethal ischemia accompanied by elevated CRE activity levels, and this effect was abolished by NVP-AAM077. Elevated brain-derived neurotrophic factor (BDNF) transcriptional activities were observed after sublethal OGD and administration of bicuculline and 4-aminopiridine. NR2A-containing NMDA receptors and CREB signaling have important functions in the induction of ischemic tolerance. This may provide potential novel therapeutic strategies to treat ischemic stroke.lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:languageenglld:pubmed
pubmed-article:20145658pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:citationSubsetIMlld:pubmed
pubmed-article:20145658pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20145658pubmed:statusMEDLINElld:pubmed
pubmed-article:20145658pubmed:monthAuglld:pubmed
pubmed-article:20145658pubmed:issn1559-7016lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:KitagawaKazuo...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:YagitaYoshiki...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:SakodaSaburoSlld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:SasakiTsutomu...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:Omura-Matsuok...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:SugiyamaYukio...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:TerasakiYasuk...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:OkazakiShuhei...lld:pubmed
pubmed-article:20145658pubmed:authorpubmed-author:OyamaNaokiNlld:pubmed
pubmed-article:20145658pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20145658pubmed:volume30lld:pubmed
pubmed-article:20145658pubmed:ownerNLMlld:pubmed
pubmed-article:20145658pubmed:authorsCompleteYlld:pubmed
pubmed-article:20145658pubmed:pagination1441-9lld:pubmed
pubmed-article:20145658pubmed:dateRevised2011-8-3lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:meshHeadingpubmed-meshheading:20145658...lld:pubmed
pubmed-article:20145658pubmed:year2010lld:pubmed
pubmed-article:20145658pubmed:articleTitleActivation of NR2A receptors induces ischemic tolerance through CREB signaling.lld:pubmed
pubmed-article:20145658pubmed:affiliationDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan. yterasak@medone.med.osaka-u.ac.jplld:pubmed
pubmed-article:20145658pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20145658pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:24409entrezgene:pubmedpubmed-article:20145658lld:entrezgene
entrez-gene:81646entrezgene:pubmedpubmed-article:20145658lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20145658lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20145658lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20145658lld:pubmed